Recent Company News

• 10:08 PM ET Feb 11, 2026
  

  Astellas Pharma reaches settlement agreements with Lupin and Zydus in Myrbetriq patent litigation (¥2500.5000, -31)

• 10:04 PM ET Feb 11, 2026
  

  Zydus Lifesciences enters into settlement agreement with Astellas in relation to Myrbetriq (INR 898.05, 0.00)

• 01:00 AM ET Feb 11, 2026
  

  NICE recommends Biomarin's Talzenna with Astellas Pharma's Xtandi for untreated hormone-relapsed metastatic prostate cancer

• 09:18 PM ET Feb 09, 2026
  

  Lupin enters into settlement and license agreement with Astellas regarding Mirabegron (INR 2198.95, 0.00)

• 10:27 PM ET Feb 08, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (269 total)

• 10:07 PM ET Feb 08, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (571 total)

• 11:10 PM ET Feb 04, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (187 total)

• 10:57 PM ET Feb 04, 2026
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:20 PM ET Feb 04, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (393 total)

• 10:13 PM ET Feb 04, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day